Author

Bello Abubakar

Observed name: B. M. Abubakar

Institution: National Hospital Abuja

Observed institutions: Birmingham City University, National Hospital Abuja, African Organisation for Research and Training in Cancer

ORCID: 0000-0002-6884-6761

Observed ORCID: 0000-0002-6884-6761

OpenAlex ID: A5013596566

Global Cancer Drug Development—A Report From the 2022 Accelerating Anticancer Agent Development and Validation Meeting

2023 · Brooke E. Wilson, Richard Sullivan, et al. · JCO Global Oncology · 13

Action for Increasing Diversity, Market Access, and Capacity in Oncology Registration Trials—Is Africa the Answer? Report From a Satellite Session of the Accelerating Anti-Cancer Agent Development and Validation Workshop

2022 · Darya Kizub, Cathyryne K. Manner, et al. · JCO Global Oncology · 10

Impact of 10-Day Fulbright Specialist Program and Project Pink Blue Education Sessions on Medical Oncology Knowledge Among Physicians Who Treat Cancer in Nigeria

2022 · M. G. Martin, R. C. W. Chidebe, et al. · Journal of Cancer Education · 9

Works count: 3

Citation count: 32

H-index: 3

I10-index: 2